Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 384 participants.
Also called NCT03359837
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 384 participants
- Sponsor
- Registry
-
NCT03359837
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03359837. Randomized; no masking; primary purpose treatment. Start 2018-01-20 (actual); primary completion 2020-06-29 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy
- Acronym
- SWITCH
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- INSULIN GLARGINE (HOE901)
- Intervention (Drug)
- Insulin Glulisine
- Intervention (Drug)
- Biphasic insulin aspart 30
- Intervention (Drug)
- Repaglinide
- Intervention (Drug)
- Acarbose
- Intervention (Drug)
- Metformin
- Lead sponsor
- Sanofi
Record details
- Record id
cardio:ct-nct03359837- Content hash
53583fafb436d9b8380bb3729d30f2395e5aa69f5a2d321fe6bbbbb584115269